董事介绍
注:董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Kurt J. Hilzinger | 男 | Chairman of the Board | 64 | 60.94万美元 | 1.94 | 2025-03-01 |
| James A. Rechtin | 男 | President and Chief Executive Officer, Director | 53 | 1557.95万美元 | 0.22 | 2025-03-01 |
| John W. Garratt | 男 | Director | 56 | 34.14万美元 | 0.17 | 2025-03-01 |
| Karen Katz | 女 | Director | 68 | 38.83万美元 | 0.06 | 2025-03-01 |
| Wayne A. I. Frederick | 男 | Director | 53 | 38.73万美元 | 0.04 | 2025-03-01 |
| Raquel C. Bono | 女 | Director | 68 | 32.75万美元 | 0.04 | 2025-03-01 |
| Marcy S. Klevorn | 女 | Director | 65 | 36.36万美元 | 0.04 | 2025-03-01 |
| Gordon Smith | 男 | Director | 66 | 32.51万美元 | 未持股 | 2025-03-01 |
| Frank A. D'Amelio | 男 | Director | 67 | 36.79万美元 | 2.06 | 2025-03-01 |
| David T. Feinberg | 男 | Director | 63 | 34.11万美元 | 0.04 | 2025-03-01 |
| Jorge S. Mesquita | 男 | Director | 63 | 36.66万美元 | 0.26 | 2025-03-01 |
高管介绍
注:高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| James A. Rechtin | 男 | President and Chief Executive Officer, Director | 53 | 1557.95万美元 | 0.22 | 2025-03-01 |
| Celeste Mellet | 女 | Chief Financial Officer | 48 | 未披露 | 未持股 | 2025-03-01 |
| Vishal Agrawal | -- | Chief Strategy and Corporate Development Officer | 50 | 未披露 | 未持股 | 2025-03-01 |
| Joseph C. Ventura | 男 | Chief Legal Officer | 48 | 359.88万美元 | 未持股 | 2025-03-01 |
| Michelle A. O'Hara | 女 | Chief Human Resources Officer | 49 | 未披露 | 未持股 | 2025-03-01 |
| George Renaudin II | 男 | President, Insurance | 56 | 615.21万美元 | 0.41 | 2025-03-01 |
| John Paul W. Felter | 男 | Senior Vice President, Chief Accounting Officer and Controller | 41 | 未披露 | 未持股 | 2025-03-01 |
| Sanjay K. Shetty | 男 | President,Center Well | 51 | 643.53万美元 | 0.08 | 2025-03-01 |
| David E. Dintenfass | -- | President, Enterprise Growth | 54 | 1806.16万美元 | 0.03 | 2025-03-01 |
| Japan A. Mehta | 男 | Chief Information Officer | 44 | 未披露 | 未持股 | 2025-03-01 |
董事简历
中英对照 |  中文 |  英文- Kurt J. Hilzinger
-
Kurt J. Hilzinger, 2003年7月被选为董事会成员,2014年1月1日被选为董事会主席。他从2010年8月起担任首席董事,直到被任命为董事长。他是Court Square Capital Partners(一家独立的私募股权公司)的合伙人,自2007年11月起担任该职位。在Court Square,他主要专注于医疗保健行业的投资。在此之前,他从2004年3月到2007年11月担任AmerisourceBergen Corporation的董事;2002年10月至2007年11月担任AmerisourceBergen Corporation的总裁兼首席运营官,2001年8月至2002年10月担任执行副总裁兼首席运营官。他还担任Outlook Therapeutics, Inc.和几家私人控股公司的董事会成员。
Kurt J. Hilzinger,has served as a member of the Board since December 2015. Since 2007, Mr. Hilzinger has served as a partner at Court Square Capital Partners L.P., an independent private equity firm, where he is responsible for investing in the healthcare sector. Since July 2003, Mr. Hilzinger also has served in various capacities as a member of the board of directors at Humana, Inc., a managed care company, including serving as Lead Director from August 2010 to January 2014, and as Chairman since January 2014. In addition, Mr. Hilzinger also has served in several roles at Cencora, Inc. (formerly AmerisourceBergen Corporation) a healthcare company, including as a member of the board of directors from March 2004 to November 2007, as the President and Chief Operating Officer from October 2002 to November 2007 and as the Executive Vice President and Chief Operating Officer from August 2001 to October 2002. Mr. Hilzinger also serves on the Visiting Committee at the Ross School of Business at the University of Michigan. Mr. Hilzinger received a B.B.A. in Accounting from the University of Michigan and is a Certified Public Accountant in Michigan. - Kurt J. Hilzinger, 2003年7月被选为董事会成员,2014年1月1日被选为董事会主席。他从2010年8月起担任首席董事,直到被任命为董事长。他是Court Square Capital Partners(一家独立的私募股权公司)的合伙人,自2007年11月起担任该职位。在Court Square,他主要专注于医疗保健行业的投资。在此之前,他从2004年3月到2007年11月担任AmerisourceBergen Corporation的董事;2002年10月至2007年11月担任AmerisourceBergen Corporation的总裁兼首席运营官,2001年8月至2002年10月担任执行副总裁兼首席运营官。他还担任Outlook Therapeutics, Inc.和几家私人控股公司的董事会成员。
- Kurt J. Hilzinger,has served as a member of the Board since December 2015. Since 2007, Mr. Hilzinger has served as a partner at Court Square Capital Partners L.P., an independent private equity firm, where he is responsible for investing in the healthcare sector. Since July 2003, Mr. Hilzinger also has served in various capacities as a member of the board of directors at Humana, Inc., a managed care company, including serving as Lead Director from August 2010 to January 2014, and as Chairman since January 2014. In addition, Mr. Hilzinger also has served in several roles at Cencora, Inc. (formerly AmerisourceBergen Corporation) a healthcare company, including as a member of the board of directors from March 2004 to November 2007, as the President and Chief Operating Officer from October 2002 to November 2007 and as the Executive Vice President and Chief Operating Officer from August 2001 to October 2002. Mr. Hilzinger also serves on the Visiting Committee at the Ross School of Business at the University of Michigan. Mr. Hilzinger received a B.B.A. in Accounting from the University of Michigan and is a Certified Public Accountant in Michigan.
- James A. Rechtin
-
James A. Rechtin, 2011年加入Humana, 2013年担任首席执行官。在过去的十年中,他领导公司从一家健康保险公司转型为今天的更广泛的医疗保健公司,将健康保险与医疗保健服务相结合。Rechtin从Envision Healthcare加入Humana,担任总裁兼首席执行官。他拥有超过22年的医疗保健经验,专注于在各种医疗集团环境中提供基于价值的护理,包括对医疗保险优势的深刻理解。加入Envision之前,Rechtin担任OptumCare (UnitedHealth Group的一部分)的总裁。在加入OptumCare之前,Rechtin于2014年加入DaVita Medical Group,担任战略高级副总裁和DaVita Medical Group加利福尼亚市场总裁。此外,他是Bain & Company的14年资深员工,突出了他在医疗保健合并和整体医疗保健行业的丰富经验。雷克廷是肯塔基人,他的职业生涯始于印第安纳波利斯一家非营利性健康和人类服务诊所的运营,并在刚果的美国和平队服役。他获得了哈佛商学院工商管理硕士学位和德堡大学文学学士学位。他担任DePauw board of Visitors的董事会成员。
James A. Rechtin,joined Humana in January 2024, having served as President and Chief Operating Officer until July 2024. Under his leadership, Humana operates as a leading integrated care delivery model centered on improving health outcomes, driving lower costs, enhancing quality, and providing a simple and personalized member and patient experience.Prior to joining Humana, Mr. Rechtin served as President and CEO at Envision Healthcare. He has more than 22 years of health care experience with a focus on the delivery of value-based care in various medical group settings, including a deep understanding of Medicare Advantage. Prior to joining Envision, Mr. Rechtin served as President of OptumCare, part of UnitedHealth Group. Before that, Mr. Rechtin was with DaVita Medical Group and played the dual roles of Senior Vice President of Corporate Strategy and President of DaVita Medical Group's California market. - James A. Rechtin, 2011年加入Humana, 2013年担任首席执行官。在过去的十年中,他领导公司从一家健康保险公司转型为今天的更广泛的医疗保健公司,将健康保险与医疗保健服务相结合。Rechtin从Envision Healthcare加入Humana,担任总裁兼首席执行官。他拥有超过22年的医疗保健经验,专注于在各种医疗集团环境中提供基于价值的护理,包括对医疗保险优势的深刻理解。加入Envision之前,Rechtin担任OptumCare (UnitedHealth Group的一部分)的总裁。在加入OptumCare之前,Rechtin于2014年加入DaVita Medical Group,担任战略高级副总裁和DaVita Medical Group加利福尼亚市场总裁。此外,他是Bain & Company的14年资深员工,突出了他在医疗保健合并和整体医疗保健行业的丰富经验。雷克廷是肯塔基人,他的职业生涯始于印第安纳波利斯一家非营利性健康和人类服务诊所的运营,并在刚果的美国和平队服役。他获得了哈佛商学院工商管理硕士学位和德堡大学文学学士学位。他担任DePauw board of Visitors的董事会成员。
- James A. Rechtin,joined Humana in January 2024, having served as President and Chief Operating Officer until July 2024. Under his leadership, Humana operates as a leading integrated care delivery model centered on improving health outcomes, driving lower costs, enhancing quality, and providing a simple and personalized member and patient experience.Prior to joining Humana, Mr. Rechtin served as President and CEO at Envision Healthcare. He has more than 22 years of health care experience with a focus on the delivery of value-based care in various medical group settings, including a deep understanding of Medicare Advantage. Prior to joining Envision, Mr. Rechtin served as President of OptumCare, part of UnitedHealth Group. Before that, Mr. Rechtin was with DaVita Medical Group and played the dual roles of Senior Vice President of Corporate Strategy and President of DaVita Medical Group's California market.
- John W. Garratt
-
John W. Garratt自2015年12月2日起担任公司执行副总裁和首席财务官。他于2014年10月加入Dollar General担任金融&战略高级副总裁,后从2015年7月到2015年12月担任代理首席财务官。加入Dollar General之前,Garratt从2004年5月到2014年10月在Yum!Brands, Inc.(世界上最大的酒店公司)担任多个职位,曾担任企业战略和金融规划领导职位。他从2013年10月到2014年10月担任KFC分部以及Pizza Hut分部和Yum Restaurants International金融副总裁和分部总监。他还从2010年3月到2013年10月担任Yum Corporate Strategy高级主管;直接向企业首席财务官报告,领导企业战略和推进重要的跨区域活动。Garratt从2004年5月到2010年3月在Yum担任多个其他金融职位。他从2002年4月到2004年5月担任Alcoa Inc.工厂总监;1999年3月到2002年4月担任General Electric 金融管理职位。他于1990年5月加入Alcoa开始自己的职业生涯,在该公司任职了将近9年。
John W. Garratt,was initially elected to the Board in February 2020. He was formerly the President and Chief Financial Officer of Dollar General Corporation, having held this position from September 2022 to June 2023. Mr. Garratt joined Dollar General in October 2014 as Senior Vice President, Finance & Strategy and subsequently served as Interim Chief Financial Officer from July 2015 to December 2015 and most recently served as Executive Vice President and Chief Financial Officer from December 2015 to September 1, 2022.Prior to joining Dollar General, Mr. Garratt held various positions of increasing responsibility with Yum! Brands, Inc., one of the world's largest restaurant companies, between May 2004 and October 2014, holding leadership positions in corporate strategy and financial planning. Mr. Garratt served as Vice President, Finance and Division Controller for the KFC division and earlier for the Pizza Hut division and for Yum Restaurants International between October 2013 and October 2014. Mr. Garratt also served as the Senior Director, Yum Corporate Strategy, from March 2010 to October 2013, reporting directly to the corporate Chief Financial Officer and leading corporate strategy as well as driving key cross-divisional initiatives. Mr. Garratt served in various other financial positions at Yum from May 2004 to March 2010.Prior to his career at Yum! Brands, Mr. Garratt served as Plant Controller for Alcoa Inc. between April 2002 and May 2004, and held various financial management positions at General Electric from March 1999 to April 2002. He began his career in May 1990 at Alcoa, where he served for approximately nine years. - John W. Garratt自2015年12月2日起担任公司执行副总裁和首席财务官。他于2014年10月加入Dollar General担任金融&战略高级副总裁,后从2015年7月到2015年12月担任代理首席财务官。加入Dollar General之前,Garratt从2004年5月到2014年10月在Yum!Brands, Inc.(世界上最大的酒店公司)担任多个职位,曾担任企业战略和金融规划领导职位。他从2013年10月到2014年10月担任KFC分部以及Pizza Hut分部和Yum Restaurants International金融副总裁和分部总监。他还从2010年3月到2013年10月担任Yum Corporate Strategy高级主管;直接向企业首席财务官报告,领导企业战略和推进重要的跨区域活动。Garratt从2004年5月到2010年3月在Yum担任多个其他金融职位。他从2002年4月到2004年5月担任Alcoa Inc.工厂总监;1999年3月到2002年4月担任General Electric 金融管理职位。他于1990年5月加入Alcoa开始自己的职业生涯,在该公司任职了将近9年。
- John W. Garratt,was initially elected to the Board in February 2020. He was formerly the President and Chief Financial Officer of Dollar General Corporation, having held this position from September 2022 to June 2023. Mr. Garratt joined Dollar General in October 2014 as Senior Vice President, Finance & Strategy and subsequently served as Interim Chief Financial Officer from July 2015 to December 2015 and most recently served as Executive Vice President and Chief Financial Officer from December 2015 to September 1, 2022.Prior to joining Dollar General, Mr. Garratt held various positions of increasing responsibility with Yum! Brands, Inc., one of the world's largest restaurant companies, between May 2004 and October 2014, holding leadership positions in corporate strategy and financial planning. Mr. Garratt served as Vice President, Finance and Division Controller for the KFC division and earlier for the Pizza Hut division and for Yum Restaurants International between October 2013 and October 2014. Mr. Garratt also served as the Senior Director, Yum Corporate Strategy, from March 2010 to October 2013, reporting directly to the corporate Chief Financial Officer and leading corporate strategy as well as driving key cross-divisional initiatives. Mr. Garratt served in various other financial positions at Yum from May 2004 to March 2010.Prior to his career at Yum! Brands, Mr. Garratt served as Plant Controller for Alcoa Inc. between April 2002 and May 2004, and held various financial management positions at General Electric from March 1999 to April 2002. He began his career in May 1990 at Alcoa, where he served for approximately nine years.
- Karen Katz
-
Karen Katz,最初于2019年9月当选为董事会成员。她最近担任Intermix, LLC的临时首席执行官(2022年6月至2022年12月)。在加入Intermix之前,她曾担任Neiman Marcus Group LTD LLC的总裁兼首席执行官(2010年至2018年2月)。内曼·马库斯集团是一家国际多品牌全渠道零售商,旗下品牌包括Neiman Marcus、Bergdorf Goodman和MyTheresa.自1985年加入Neiman Marcus以来,她曾担任公司商户、商店和电子商务组织的主要执行和领导职务,担任商店执行副总裁、Neiman Marcus Group主席办公室成员、Neiman Marcus Online总裁、Neiman Marcus stores总裁兼首席执行官。
Karen Katz,was initially elected to the Board in September 2019. She was most recently interim CEO of Intermix, LLC from June 2022 to December 2022. Prior to Intermix, Ms. Katz served as the President and CEO of Neiman Marcus Group LTD LLC from 2010 to February 2018. Neiman Marcus Group is an international multibrand omni-channel retailer whose portfolio of brands includes Neiman Marcus, Bergdorf Goodman and MyTheresa. Having joined Neiman Marcus in 1985, Ms. Katz served in key executive and leadership roles in the company's merchant, stores and eCommerce organizations as Executive Vice President—Stores, a member of the Office of the Chairman of Neiman Marcus Group, and President, Neiman Marcus Online, and President and CEO, Neiman Marcus Stores. - Karen Katz,最初于2019年9月当选为董事会成员。她最近担任Intermix, LLC的临时首席执行官(2022年6月至2022年12月)。在加入Intermix之前,她曾担任Neiman Marcus Group LTD LLC的总裁兼首席执行官(2010年至2018年2月)。内曼·马库斯集团是一家国际多品牌全渠道零售商,旗下品牌包括Neiman Marcus、Bergdorf Goodman和MyTheresa.自1985年加入Neiman Marcus以来,她曾担任公司商户、商店和电子商务组织的主要执行和领导职务,担任商店执行副总裁、Neiman Marcus Group主席办公室成员、Neiman Marcus Online总裁、Neiman Marcus stores总裁兼首席执行官。
- Karen Katz,was initially elected to the Board in September 2019. She was most recently interim CEO of Intermix, LLC from June 2022 to December 2022. Prior to Intermix, Ms. Katz served as the President and CEO of Neiman Marcus Group LTD LLC from 2010 to February 2018. Neiman Marcus Group is an international multibrand omni-channel retailer whose portfolio of brands includes Neiman Marcus, Bergdorf Goodman and MyTheresa. Having joined Neiman Marcus in 1985, Ms. Katz served in key executive and leadership roles in the company's merchant, stores and eCommerce organizations as Executive Vice President—Stores, a member of the Office of the Chairman of Neiman Marcus Group, and President, Neiman Marcus Online, and President and CEO, Neiman Marcus Stores.
- Wayne A. I. Frederick
-
Wayne A. I. Frederick,自2020年10月起担任董事会成员。自2024年11月2日起,他担任美国癌症协会及其倡导附属机构美国癌症协会癌症行动网络(ACS CAN)的临时首席执行官。他是Howard University College of Medicine杰出的Charles R. Drew外科教授,也是Howard University的名誉校长,此前曾担任Howard University的校长(2014年7月至2023年9月)。在2014年被任命为霍华德大学校长之前,他曾担任霍华德大学的教务长和首席学术官。Frederick博士是一名执业癌症外科医生,杰出的研究人员和学者,以及许多同行评审文章,书籍章节,摘要和社论的作者。作为医疗保健差异和医学教育领域公认的专家,他的医学研究重点是减少癌症治疗结果中的种族,民族和性别差异,特别强调胃肠道癌症。在他的职业生涯中,Frederick博士获得了许多认可,包括德克萨斯大学MD安德森癌症中心的杰出校友奖。2021年,他被纽约卡内基基金会(Carnegie Corporation of New York)表彰为加强美国做出贡献的34名入籍美国公民之一。他目前担任Humana, Inc., Tempus AI, Inc.和Workday, Inc.的董事会成员,并在担任临时首席执行官之前担任美国癌症协会董事会成员。他是几个专业协会的活跃成员,包括美国外科协会和美国外科医生学院。最近,他被任命为Mutual of America的高级独立董事,并担任波士顿咨询集团(Boston Consulting Group)的顾问。他获得了霍华德大学的理学学士、医学博士和工商管理硕士学位。
Wayne A. I. Frederick,has served on Board of Directors since October 2020. Since November 2, 2024, he has served as the Interim Chief Executive Officer of the American Cancer Society and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN). Dr. Frederick is the distinguished Charles R. Drew Professor of Surgery at the Howard University College of Medicine as well as President Emeritus of Howard University, having previously served as President of Howard University from July 2014 to September 2023. Prior to being appointed President of Howard in 2014, Dr. Frederick served as Howard's Provost and Chief Academic Officer. Dr. Frederick is a practicing cancer surgeon, distinguished researcher and scholar, and the author of numerous peer-reviewed articles, book chapters, abstracts, and editorials. A widely recognized expert in the fields of health care disparities and medical education, his medical research focuses on reducing racial, ethnic, and gender disparities in cancer care outcomes, with a particular emphasis on gastrointestinal cancers. Throughout his career, Dr. Frederick has received numerous recognitions, including the Distinguished Alumnus Award from the University of Texas MD Anderson Cancer Center. In 2021, he was recognized by the Carnegie Corporation of New York as one of 34 naturalized citizens honored for their contributions to strengthening the United States. Dr. Frederick currently serves on the boards of Humana, Inc., Tempus AI, Inc. and Workday, Inc. and served on the American Cancer Society Board before assuming the role of Interim Chief Executive Officer. He is an active member of several professional associations, including the American Surgical Association and the American College of Surgeons. Recently, he was appointed senior independent director of Mutual of America and also serves as an advisor for Boston Consulting Group. He received his Bachelor of Science, Doctor of Medicine, and Master of Business Administration from Howard University. - Wayne A. I. Frederick,自2020年10月起担任董事会成员。自2024年11月2日起,他担任美国癌症协会及其倡导附属机构美国癌症协会癌症行动网络(ACS CAN)的临时首席执行官。他是Howard University College of Medicine杰出的Charles R. Drew外科教授,也是Howard University的名誉校长,此前曾担任Howard University的校长(2014年7月至2023年9月)。在2014年被任命为霍华德大学校长之前,他曾担任霍华德大学的教务长和首席学术官。Frederick博士是一名执业癌症外科医生,杰出的研究人员和学者,以及许多同行评审文章,书籍章节,摘要和社论的作者。作为医疗保健差异和医学教育领域公认的专家,他的医学研究重点是减少癌症治疗结果中的种族,民族和性别差异,特别强调胃肠道癌症。在他的职业生涯中,Frederick博士获得了许多认可,包括德克萨斯大学MD安德森癌症中心的杰出校友奖。2021年,他被纽约卡内基基金会(Carnegie Corporation of New York)表彰为加强美国做出贡献的34名入籍美国公民之一。他目前担任Humana, Inc., Tempus AI, Inc.和Workday, Inc.的董事会成员,并在担任临时首席执行官之前担任美国癌症协会董事会成员。他是几个专业协会的活跃成员,包括美国外科协会和美国外科医生学院。最近,他被任命为Mutual of America的高级独立董事,并担任波士顿咨询集团(Boston Consulting Group)的顾问。他获得了霍华德大学的理学学士、医学博士和工商管理硕士学位。
- Wayne A. I. Frederick,has served on Board of Directors since October 2020. Since November 2, 2024, he has served as the Interim Chief Executive Officer of the American Cancer Society and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN). Dr. Frederick is the distinguished Charles R. Drew Professor of Surgery at the Howard University College of Medicine as well as President Emeritus of Howard University, having previously served as President of Howard University from July 2014 to September 2023. Prior to being appointed President of Howard in 2014, Dr. Frederick served as Howard's Provost and Chief Academic Officer. Dr. Frederick is a practicing cancer surgeon, distinguished researcher and scholar, and the author of numerous peer-reviewed articles, book chapters, abstracts, and editorials. A widely recognized expert in the fields of health care disparities and medical education, his medical research focuses on reducing racial, ethnic, and gender disparities in cancer care outcomes, with a particular emphasis on gastrointestinal cancers. Throughout his career, Dr. Frederick has received numerous recognitions, including the Distinguished Alumnus Award from the University of Texas MD Anderson Cancer Center. In 2021, he was recognized by the Carnegie Corporation of New York as one of 34 naturalized citizens honored for their contributions to strengthening the United States. Dr. Frederick currently serves on the boards of Humana, Inc., Tempus AI, Inc. and Workday, Inc. and served on the American Cancer Society Board before assuming the role of Interim Chief Executive Officer. He is an active member of several professional associations, including the American Surgical Association and the American College of Surgeons. Recently, he was appointed senior independent director of Mutual of America and also serves as an advisor for Boston Consulting Group. He received his Bachelor of Science, Doctor of Medicine, and Master of Business Administration from Howard University.
- Raquel C. Bono
-
Raquel C. Bono最初于2020年9月当选为董事会成员。她是RCB咨询公司的负责人,自2019年10月起担任负责人。博诺博士是一名获得董事会认证的创伤外科医生,美国海军医疗队退役副上将,此前曾担任国防卫生局(DHA)首席执行官和局长。在首席执行官和局长职位上,博诺博士领导了一个联合、综合作战支援机构,使美军医疗服务的所有分支机构能够在和平时期和战争时期向作战司令部提供医疗保健服务。博诺博士为陆军、海军、空军和海军陆战队整合了一个前所未有的价值500亿美元的全球医疗企业,由50家医院和300家诊所组成,为950万军人提供医疗服务,监督国防部电子医疗记录的部署,并促进了双方的合作最大的联邦卫生系统的国防部和退伍军人事务部(VA)。博诺博士自1991年起担任美国外科学会(ACS)研究员,曾在ACS理事会和州长健康政策和倡导工作组任职。先后荣获国防杰出服役奖章、国防高级服役奖章3枚、功勋军团奖章4枚、功勋服役奖章2枚、海军陆战队表彰奖章2枚。博诺博士也在几家私人控股公司的董事会任职。
Raquel C. Bono, was initially elected to the Board in September 2020. Dr. Bono is a Principal at RCB Consulting having held this position since October 2019, and serves as CEO and Chief of Surgical Innovation at Medical iSight, having held this position since 2023. Dr. Bono was formerly Chief Health Officer at Viking Cruises from November 2020 until her retirement in December 2023.Prior to Viking Cruises, Dr. Bono, a board-certified trauma surgeon and retired Vice Admiral, U.S. Navy Medical Corps, served as the Chief Executive Officer and Director for the Defense Health Agency (DHA). In this capacity, Dr. Bono led a joint, integrated combat support agency that enables all branches of the U.S. military medical services to provide health care services to combatant commands in times of both peace and war. Dr. Bono integrated an unprecedented $50 billion worldwide health care enterprise for the Army, Navy, Air Force, and Marine Corps, composed of 50 hospitals and 300 clinics that provide care to 9.5 million military personnel, oversaw the Department of Defense deployment of the electronic health record, and facilitated the collaboration between the largest federated health systems of the Department of Defense and Department of Veterans Affairs (VA).An American College of Surgeons (ACS) Fellow since 1991, Dr. Bono served on the ACS Board of Governors and the Governors Health Policy and Advocacy Workgroup. She has been honored with the Defense Distinguished Service Medal, three Defense Superior Service Medals, four Legion of Merit Medals, two Meritorious Service Medals, and two Navy and Marine Corps Commendation medals. - Raquel C. Bono最初于2020年9月当选为董事会成员。她是RCB咨询公司的负责人,自2019年10月起担任负责人。博诺博士是一名获得董事会认证的创伤外科医生,美国海军医疗队退役副上将,此前曾担任国防卫生局(DHA)首席执行官和局长。在首席执行官和局长职位上,博诺博士领导了一个联合、综合作战支援机构,使美军医疗服务的所有分支机构能够在和平时期和战争时期向作战司令部提供医疗保健服务。博诺博士为陆军、海军、空军和海军陆战队整合了一个前所未有的价值500亿美元的全球医疗企业,由50家医院和300家诊所组成,为950万军人提供医疗服务,监督国防部电子医疗记录的部署,并促进了双方的合作最大的联邦卫生系统的国防部和退伍军人事务部(VA)。博诺博士自1991年起担任美国外科学会(ACS)研究员,曾在ACS理事会和州长健康政策和倡导工作组任职。先后荣获国防杰出服役奖章、国防高级服役奖章3枚、功勋军团奖章4枚、功勋服役奖章2枚、海军陆战队表彰奖章2枚。博诺博士也在几家私人控股公司的董事会任职。
- Raquel C. Bono, was initially elected to the Board in September 2020. Dr. Bono is a Principal at RCB Consulting having held this position since October 2019, and serves as CEO and Chief of Surgical Innovation at Medical iSight, having held this position since 2023. Dr. Bono was formerly Chief Health Officer at Viking Cruises from November 2020 until her retirement in December 2023.Prior to Viking Cruises, Dr. Bono, a board-certified trauma surgeon and retired Vice Admiral, U.S. Navy Medical Corps, served as the Chief Executive Officer and Director for the Defense Health Agency (DHA). In this capacity, Dr. Bono led a joint, integrated combat support agency that enables all branches of the U.S. military medical services to provide health care services to combatant commands in times of both peace and war. Dr. Bono integrated an unprecedented $50 billion worldwide health care enterprise for the Army, Navy, Air Force, and Marine Corps, composed of 50 hospitals and 300 clinics that provide care to 9.5 million military personnel, oversaw the Department of Defense deployment of the electronic health record, and facilitated the collaboration between the largest federated health systems of the Department of Defense and Department of Veterans Affairs (VA).An American College of Surgeons (ACS) Fellow since 1991, Dr. Bono served on the ACS Board of Governors and the Governors Health Policy and Advocacy Workgroup. She has been honored with the Defense Distinguished Service Medal, three Defense Superior Service Medals, four Legion of Merit Medals, two Meritorious Service Medals, and two Navy and Marine Corps Commendation medals.
- Marcy S. Klevorn
-
Marcy S. Klevorn最初于2021年2月当选为董事会成员。Klevorn女士曾于2019年5月担任福特汽车公司的首席转型官,直至2019年10月退休。在首席转型官职位上,她通过帮助完善福特汽车公司治理系统、促进企业更快地采用敏捷团队以及确保整个企业的流程改进,加速了福特汽车公司的转型。她还促进了与关键技术合作伙伴的战略合作,并支持福特汽车公司的多元化努力。Klevorn女士于1983年加入福特汽车公司,担任福特汽车公司信息技术部门的主要执行和领导职务,包括首席信息官办公室主任和集团信息技术副总裁,负责监督福特IT工具和人才的转型。Klevorn女士还曾担任福特汽车公司(Ford Motor Company)旗下的福特智能移动有限责任公司(Ford Smart Mobility LLC)的执行副总裁兼总裁,负责监督某些收购和其他投资,并帮助加快公司在新兴移动服务和全球数据洞察与分析领域的设计、建设、发展和投资计划。Klevorn女士目前在北方信托公司和一些私营公司的董事会任职。
Marcy S. Klevorn,was initially elected to the Board in February 2021. Ms. Klevorn was formerly the Chief Transformation Officer of Ford Motor Company from May 2019 until her retirement in October 2019. In this role, she accelerated the company's transformation by helping to refine its corporate governance systems, facilitate faster adoption of agile teams across the business and ensure process improvements across the enterprise. She also facilitated strategic partnerships with key technology partners and supported the company's diversity efforts. Having joined Ford Motor Company in 1983, Ms. Klevorn served in key executive and leadership roles within the company's information technology organization including Director of the Office of the Chief Information Officer and Group Vice President of Information Technology. Ms. Klevorn also served as Executive Vice President and President of Ford Smart Mobility LLC, a division of Ford Motor Company, where she oversaw certain acquisitions and other investments and helped to accelerate the company's plans to design, build, grow and invest in emerging mobility services and global data insight and analytics. - Marcy S. Klevorn最初于2021年2月当选为董事会成员。Klevorn女士曾于2019年5月担任福特汽车公司的首席转型官,直至2019年10月退休。在首席转型官职位上,她通过帮助完善福特汽车公司治理系统、促进企业更快地采用敏捷团队以及确保整个企业的流程改进,加速了福特汽车公司的转型。她还促进了与关键技术合作伙伴的战略合作,并支持福特汽车公司的多元化努力。Klevorn女士于1983年加入福特汽车公司,担任福特汽车公司信息技术部门的主要执行和领导职务,包括首席信息官办公室主任和集团信息技术副总裁,负责监督福特IT工具和人才的转型。Klevorn女士还曾担任福特汽车公司(Ford Motor Company)旗下的福特智能移动有限责任公司(Ford Smart Mobility LLC)的执行副总裁兼总裁,负责监督某些收购和其他投资,并帮助加快公司在新兴移动服务和全球数据洞察与分析领域的设计、建设、发展和投资计划。Klevorn女士目前在北方信托公司和一些私营公司的董事会任职。
- Marcy S. Klevorn,was initially elected to the Board in February 2021. Ms. Klevorn was formerly the Chief Transformation Officer of Ford Motor Company from May 2019 until her retirement in October 2019. In this role, she accelerated the company's transformation by helping to refine its corporate governance systems, facilitate faster adoption of agile teams across the business and ensure process improvements across the enterprise. She also facilitated strategic partnerships with key technology partners and supported the company's diversity efforts. Having joined Ford Motor Company in 1983, Ms. Klevorn served in key executive and leadership roles within the company's information technology organization including Director of the Office of the Chief Information Officer and Group Vice President of Information Technology. Ms. Klevorn also served as Executive Vice President and President of Ford Smart Mobility LLC, a division of Ford Motor Company, where she oversaw certain acquisitions and other investments and helped to accelerate the company's plans to design, build, grow and invest in emerging mobility services and global data insight and analytics.
- Gordon Smith
-
Gordon Smith,担任领先的私人投资公司Clayton,Dubilier & Rice LLC(CD & R)Funds的运营顾问。他此前担任JPMorgan Chase & Co.(JPMorgan)的联席总裁兼联席首席运营官,并担任摩根大通运营委员会成员,从2018年到2022年1月退休,帮助监督公司业务和运营的各个方面。他在摩根大通的职业生涯始于2007年,跨越了15年,在此期间,他还在2012年至2021年期间担任消费者和社区银行业务的首席执行官。在加入摩根大通之前,Smith在美国运通工作了超过25年,在那里他领导并管理了包括全球商业卡业务在内的多项业务。
Gordon Smith,was initially elected to the Board in October 2024. Mr. Smith was formerly the Co-President and Co-Chief Operating Officer of JPMorgan Chase & Co. (JPMorgan), having held these positions from 2018 until retiring in January of 2022. In this role, Mr. Smith served as a member of the firm's Operating Committee and helped oversee all aspects of the company's business and operations.Mr. Smith's career at JPMorgan began in 2007 and spanned 15 years, where he previously served as Chief Executive Officer of Consumer & Community Banking (2012-2021), and prior to that held various roles of increasing responsibility, including as CEO of Chase Card Services, Auto Finance and Student Lending (2011-2012), and CEO of Chase Card Services (2007-2011).Prior to his time at JPMorgan, Mr. Smith spent more than 25 years at American Express, where he led and managed several businesses, including the Global Commercial Card Business. Mr. Smith is also an operating advisor to Clayton Dubilier & Rice. - Gordon Smith,担任领先的私人投资公司Clayton,Dubilier & Rice LLC(CD & R)Funds的运营顾问。他此前担任JPMorgan Chase & Co.(JPMorgan)的联席总裁兼联席首席运营官,并担任摩根大通运营委员会成员,从2018年到2022年1月退休,帮助监督公司业务和运营的各个方面。他在摩根大通的职业生涯始于2007年,跨越了15年,在此期间,他还在2012年至2021年期间担任消费者和社区银行业务的首席执行官。在加入摩根大通之前,Smith在美国运通工作了超过25年,在那里他领导并管理了包括全球商业卡业务在内的多项业务。
- Gordon Smith,was initially elected to the Board in October 2024. Mr. Smith was formerly the Co-President and Co-Chief Operating Officer of JPMorgan Chase & Co. (JPMorgan), having held these positions from 2018 until retiring in January of 2022. In this role, Mr. Smith served as a member of the firm's Operating Committee and helped oversee all aspects of the company's business and operations.Mr. Smith's career at JPMorgan began in 2007 and spanned 15 years, where he previously served as Chief Executive Officer of Consumer & Community Banking (2012-2021), and prior to that held various roles of increasing responsibility, including as CEO of Chase Card Services, Auto Finance and Student Lending (2011-2012), and CEO of Chase Card Services (2007-2011).Prior to his time at JPMorgan, Mr. Smith spent more than 25 years at American Express, where he led and managed several businesses, including the Global Commercial Card Business. Mr. Smith is also an operating advisor to Clayton Dubilier & Rice.
- Frank A. D'Amelio
-
Frank A. D'Amelio,从2010年12月到2022年5月退休,担任辉瑞公司(Pfizer Inc.)的执行副总裁兼首席财务官(“CFO”),这是一家以研究为基础的全球生物制药公司,在此期间,他还负责业务运营和全球供应链。在此之前,他从2007年到2010年12月担任Pfizer的高级副总裁兼首席财务官。在加入Pfizer之前,他曾担任Alcatel-Lucent(一家通信公司)的业务运营和集成高级执行副总裁(2006年12月至2007年8月),以及朗讯科技公司(Lucent Technologies, Inc.)的各种高级领导职务,特别是2001年至2005年担任首席财务官,2005年至2006年担任首席运营官。
Frank A. D'Amelio,Served as Executive Vice President and Chief Financial Officer of Pfizer Inc., a global pharmaceutical company from 2020 to 2022, and a member of Pfizer's Senior Executive Leadership Team;Served as Pfizer's Executive Vice President, Global Supply and Business Operations from 2020 through 2021; Executive Vice President, Business Operations and Global Supply and Chief Financial Officer from 2018 until 2020 and Executive Vice President, Business Operations and Chief Financial Officer from 2010 to 2018;Joined Pfizer in 2007 and held various positions, including Senior Vice President and Chief Financial Officer;Led many acquisitions and partnerships valued at nearly $200 billion, including numerous transformative transactions, such as the acquisition of Wyeth as well as the divestitures of the animal health, consumer health and mature products businesses;Oversaw Pfizer's information technology, procurement, real estate, business development and global supply chain during his tenure;Served as Senior Executive Vice President of Integration and Chief Administrative Officer at Alcatel-Lucent, S.A. from 2006 to 2007;Served as Chief Operating Officer of Lucent Technologies, with responsibility for leading business operations, including sales, the product groups, the services business, the supply chain, information technology operations, human resources and labor relations from in 2006;Appointed Executive Vice President, Administration, and Chief Financial Officer of Lucent from 2001 until 2006;Formerly served as a member of the National Advisory Board of JPMorgan Chase & Co.Education:Bachelor's degree in Accounting from St. Peter's College,Master of Business Administration in Finance from St. John's University. - Frank A. D'Amelio,从2010年12月到2022年5月退休,担任辉瑞公司(Pfizer Inc.)的执行副总裁兼首席财务官(“CFO”),这是一家以研究为基础的全球生物制药公司,在此期间,他还负责业务运营和全球供应链。在此之前,他从2007年到2010年12月担任Pfizer的高级副总裁兼首席财务官。在加入Pfizer之前,他曾担任Alcatel-Lucent(一家通信公司)的业务运营和集成高级执行副总裁(2006年12月至2007年8月),以及朗讯科技公司(Lucent Technologies, Inc.)的各种高级领导职务,特别是2001年至2005年担任首席财务官,2005年至2006年担任首席运营官。
- Frank A. D'Amelio,Served as Executive Vice President and Chief Financial Officer of Pfizer Inc., a global pharmaceutical company from 2020 to 2022, and a member of Pfizer's Senior Executive Leadership Team;Served as Pfizer's Executive Vice President, Global Supply and Business Operations from 2020 through 2021; Executive Vice President, Business Operations and Global Supply and Chief Financial Officer from 2018 until 2020 and Executive Vice President, Business Operations and Chief Financial Officer from 2010 to 2018;Joined Pfizer in 2007 and held various positions, including Senior Vice President and Chief Financial Officer;Led many acquisitions and partnerships valued at nearly $200 billion, including numerous transformative transactions, such as the acquisition of Wyeth as well as the divestitures of the animal health, consumer health and mature products businesses;Oversaw Pfizer's information technology, procurement, real estate, business development and global supply chain during his tenure;Served as Senior Executive Vice President of Integration and Chief Administrative Officer at Alcatel-Lucent, S.A. from 2006 to 2007;Served as Chief Operating Officer of Lucent Technologies, with responsibility for leading business operations, including sales, the product groups, the services business, the supply chain, information technology operations, human resources and labor relations from in 2006;Appointed Executive Vice President, Administration, and Chief Financial Officer of Lucent from 2001 until 2006;Formerly served as a member of the National Advisory Board of JPMorgan Chase & Co.Education:Bachelor's degree in Accounting from St. Peter's College,Master of Business Administration in Finance from St. John's University.
- David T. Feinberg
-
David T. Feinberg,最初于2022年3月当选为董事会成员。Feinberg博士是甲骨文健康公司的董事长,他致力于使医疗保健更容易获得、负担得起和公平。他的工作推进了思想领导力和战略,通过开放和连接的医疗保健生态系统释放数据的治愈力量。此前,他曾担任Cerner Corporation(现为Oracle Health)的总裁、首席执行官和董事会成员。在这个职位上,Feinberg博士专注于提供工具和技术,帮助护理人员优化患者和社区的健康。Feinberg从谷歌加入Cerner,自2019年以来,他担任谷歌Health副总裁,领导谷歌的全球健康工作,将谷歌和Alphabet的团队聚集在一起,Humana Inc.利用人工智能、产品专业知识和硬件来应对医疗保健领域的一些最大挑战,并负责组织和创新谷歌的各种医疗保健计划。在b谷歌之前,他曾担任Geisinger Health的总裁兼首席执行官,在那里他领导了运营转型,并推动了Humana Inc. e的新平台和工具,包括称为统一数据架构的IT系统,该系统允许公司将大数据集成到现有的数据分析和管理系统中。在Geisinger任职期间,Feinberg博士还引入了一些项目和服务,以更加关注精准医疗和更好的患者护理。在加入Geisinger之前,Feinberg博士在加州大学洛杉矶分校工作了20多年,担任过许多领导职务,包括加州大学洛杉矶分校健康科学的总裁、首席执行官和副校长,加州大学洛杉矶分校医院系统的副校长和首席执行官,加州大学洛杉矶分校罗纳德·里根医疗中心的首席执行官。Feinberg在加州大学伯克利分校获得本科学位。他以优异的成绩毕业于健康科学大学/芝加哥医学院。他在洛约拉大学医学中心完成了儿科实习,并在加州大学洛杉矶分校医学院完成了精神病学、成瘾精神病学、儿童和青少年精神病学的住院医师和奖学金培训。他获得了佩珀代因大学的工商管理硕士学位。Feinberg博士是Alpha Omega Alpha医学荣誉协会的成员,美国精神病学协会的杰出会员,并获得美国儿童与青少年精神病学学会颁发的Cancro学术领导奖。他还担任Douglas Emmett Inc.的董事会成员。
David T. Feinberg,was initially elected to the Board in March 2022. Dr. Feinberg is Chairman of Oracle Health, where he is committed to making healthcare more accessible, affordable, and equitable. His work advances thought leadership and strategy related to unleashing the healing power of data through an open and connected healthcare ecosystem. Previously, Dr. Feinberg served as President and Chief Executive Officer and member of the Board of Directors of Cerner Corporation (Cerner), which is now Oracle Health. In that role Dr. Feinberg focused on delivering tools and technology to help caregivers optimize the health of their patients and communities.Dr. Feinberg joined Cerner from Google, where he held the position of Vice President of Google Health since 2019 and led Google's worldwide health efforts, bringing together groups from across Google and Alphabet that Humana Inc. ed artificial intelligence, product expertise and hardware to tackle some of healthcare's biggest challenges, and was responsible for organizing and innovating Google's various healthcare initiatives. Prior to Google, he served as President and CEO of Geisinger Health where he led an operational turnaround, and pushed the Humana Inc. e of new platforms and tools, including an IT system called a Unified Data Architecture that allowed the company to integrate big data into existing data analytics and management systems. During his Geisinger tenure, Dr. Feinberg also introduced programs and services to put a greater focus on precision medicine and better patient care. Prior to Geisinger, Dr. Feinberg worked at UCLA for more than 20 years and served in a number of leadership roles, including President, CEO and Associate Vice Chancellor of UCLA Health Sciences, Vice Chancellor and CEO for the UCLA Hospital System, and CEO of UCLA's Ronald Reagan Medical Center.Dr. Feinberg earned his undergraduate degree at the University of California, Berkeley. He graduated with distinction from the University of Health Sciences/Chicago Medical School. He completed an internship in pediatrics at Loyola University Medical Center, and residency and fellowship training in psychiatry, addiction psychiatry, and child and adolescent psychiatry at the UCLA School of Medicine. He earned a Master of Business Administration from Pepperdine University. Dr. Feinberg is a member of the Alpha Omega Alpha Medical Honor Society, a Distinguished Fellow of American Psychiatric Association and received the Cancro Academic Leadership Award from the American Academy of Child & Adolescent Psychiatry. - David T. Feinberg,最初于2022年3月当选为董事会成员。Feinberg博士是甲骨文健康公司的董事长,他致力于使医疗保健更容易获得、负担得起和公平。他的工作推进了思想领导力和战略,通过开放和连接的医疗保健生态系统释放数据的治愈力量。此前,他曾担任Cerner Corporation(现为Oracle Health)的总裁、首席执行官和董事会成员。在这个职位上,Feinberg博士专注于提供工具和技术,帮助护理人员优化患者和社区的健康。Feinberg从谷歌加入Cerner,自2019年以来,他担任谷歌Health副总裁,领导谷歌的全球健康工作,将谷歌和Alphabet的团队聚集在一起,Humana Inc.利用人工智能、产品专业知识和硬件来应对医疗保健领域的一些最大挑战,并负责组织和创新谷歌的各种医疗保健计划。在b谷歌之前,他曾担任Geisinger Health的总裁兼首席执行官,在那里他领导了运营转型,并推动了Humana Inc. e的新平台和工具,包括称为统一数据架构的IT系统,该系统允许公司将大数据集成到现有的数据分析和管理系统中。在Geisinger任职期间,Feinberg博士还引入了一些项目和服务,以更加关注精准医疗和更好的患者护理。在加入Geisinger之前,Feinberg博士在加州大学洛杉矶分校工作了20多年,担任过许多领导职务,包括加州大学洛杉矶分校健康科学的总裁、首席执行官和副校长,加州大学洛杉矶分校医院系统的副校长和首席执行官,加州大学洛杉矶分校罗纳德·里根医疗中心的首席执行官。Feinberg在加州大学伯克利分校获得本科学位。他以优异的成绩毕业于健康科学大学/芝加哥医学院。他在洛约拉大学医学中心完成了儿科实习,并在加州大学洛杉矶分校医学院完成了精神病学、成瘾精神病学、儿童和青少年精神病学的住院医师和奖学金培训。他获得了佩珀代因大学的工商管理硕士学位。Feinberg博士是Alpha Omega Alpha医学荣誉协会的成员,美国精神病学协会的杰出会员,并获得美国儿童与青少年精神病学学会颁发的Cancro学术领导奖。他还担任Douglas Emmett Inc.的董事会成员。
- David T. Feinberg,was initially elected to the Board in March 2022. Dr. Feinberg is Chairman of Oracle Health, where he is committed to making healthcare more accessible, affordable, and equitable. His work advances thought leadership and strategy related to unleashing the healing power of data through an open and connected healthcare ecosystem. Previously, Dr. Feinberg served as President and Chief Executive Officer and member of the Board of Directors of Cerner Corporation (Cerner), which is now Oracle Health. In that role Dr. Feinberg focused on delivering tools and technology to help caregivers optimize the health of their patients and communities.Dr. Feinberg joined Cerner from Google, where he held the position of Vice President of Google Health since 2019 and led Google's worldwide health efforts, bringing together groups from across Google and Alphabet that Humana Inc. ed artificial intelligence, product expertise and hardware to tackle some of healthcare's biggest challenges, and was responsible for organizing and innovating Google's various healthcare initiatives. Prior to Google, he served as President and CEO of Geisinger Health where he led an operational turnaround, and pushed the Humana Inc. e of new platforms and tools, including an IT system called a Unified Data Architecture that allowed the company to integrate big data into existing data analytics and management systems. During his Geisinger tenure, Dr. Feinberg also introduced programs and services to put a greater focus on precision medicine and better patient care. Prior to Geisinger, Dr. Feinberg worked at UCLA for more than 20 years and served in a number of leadership roles, including President, CEO and Associate Vice Chancellor of UCLA Health Sciences, Vice Chancellor and CEO for the UCLA Hospital System, and CEO of UCLA's Ronald Reagan Medical Center.Dr. Feinberg earned his undergraduate degree at the University of California, Berkeley. He graduated with distinction from the University of Health Sciences/Chicago Medical School. He completed an internship in pediatrics at Loyola University Medical Center, and residency and fellowship training in psychiatry, addiction psychiatry, and child and adolescent psychiatry at the UCLA School of Medicine. He earned a Master of Business Administration from Pepperdine University. Dr. Feinberg is a member of the Alpha Omega Alpha Medical Honor Society, a Distinguished Fellow of American Psychiatric Association and received the Cancro Academic Leadership Award from the American Academy of Child & Adolescent Psychiatry.
- Jorge S. Mesquita
-
Jorge S. Mesquita,最初于2021年2月当选为董事会成员。他曾担任BlueTriton Brands的首席执行官(从2021年7月到2022年3月)。在此职位上,Mesquita先生领导公司扩大市场领导地位,推进对可持续发展和环境管理的承诺,并实现公司水品牌组合的潜力。在加入BlueTriton Brands之前,Mesquita先生曾于2014年12月至2019年2月担任强生公司(J&J)的执行副总裁兼全球消费者主席,负责通过全面的转型战略提高强生消费者业务的竞争力。在此职位上,他曾任职于J&J的执行委员会,并领导消费者集团运营委员会。在此之前,他在宝洁公司(P&G)工作了29年,在那里他担任领导宝洁消费品业务部门的各种职务。在宝洁任职期间,他曾担任新业务创造和创新集团总裁(2012年3月至2013年6月),集团总裁(2012年1月至2012年3月),特别任务集团总裁(2012年1月至2012年3月),全球织物护理集团总裁(2007年至2011年),全球家庭护理总裁(2001年至2007年),还担任商业产品总裁和宝洁专业总裁(2006年至2007年)。他目前担任Mondelez International, Inc.的董事会成员。
Jorge S. Mesquita,served as Chief Executive Officer of BlueTriton Brands, a beverage company that offers regional spring water and national purified water brands, from July 2021 to March 2022. Prior to that, he was Executive Vice President and Worldwide Chairman, Consumer of Johnson & Johnson, a global healthcare products company, from 2014 until 2019. He also served on J&J's Executive Committee and led the Consumer Group Operating Committee. Mr. Mesquita was an advisor to Cinven, a UK private equity firm, from 2020 to 2021.Mr. Mesquita was employed by Procter & Gamble, a global marketer of consumer products, in various marketing and leadership capacities for 29 years from 1984 to 2013. During his tenure at P&G, he served as Group President – New Business Creation and Innovation from 2012 until 2013; Group President – Special Assignment from January 2012 until March 2012; Group President, Global Fabric Care from 2007 to 2011; President, Global Home Care from 2001 to 2007; and President of Commercial Products and President of P&G Professional from 2006 to 2007. - Jorge S. Mesquita,最初于2021年2月当选为董事会成员。他曾担任BlueTriton Brands的首席执行官(从2021年7月到2022年3月)。在此职位上,Mesquita先生领导公司扩大市场领导地位,推进对可持续发展和环境管理的承诺,并实现公司水品牌组合的潜力。在加入BlueTriton Brands之前,Mesquita先生曾于2014年12月至2019年2月担任强生公司(J&J)的执行副总裁兼全球消费者主席,负责通过全面的转型战略提高强生消费者业务的竞争力。在此职位上,他曾任职于J&J的执行委员会,并领导消费者集团运营委员会。在此之前,他在宝洁公司(P&G)工作了29年,在那里他担任领导宝洁消费品业务部门的各种职务。在宝洁任职期间,他曾担任新业务创造和创新集团总裁(2012年3月至2013年6月),集团总裁(2012年1月至2012年3月),特别任务集团总裁(2012年1月至2012年3月),全球织物护理集团总裁(2007年至2011年),全球家庭护理总裁(2001年至2007年),还担任商业产品总裁和宝洁专业总裁(2006年至2007年)。他目前担任Mondelez International, Inc.的董事会成员。
- Jorge S. Mesquita,served as Chief Executive Officer of BlueTriton Brands, a beverage company that offers regional spring water and national purified water brands, from July 2021 to March 2022. Prior to that, he was Executive Vice President and Worldwide Chairman, Consumer of Johnson & Johnson, a global healthcare products company, from 2014 until 2019. He also served on J&J's Executive Committee and led the Consumer Group Operating Committee. Mr. Mesquita was an advisor to Cinven, a UK private equity firm, from 2020 to 2021.Mr. Mesquita was employed by Procter & Gamble, a global marketer of consumer products, in various marketing and leadership capacities for 29 years from 1984 to 2013. During his tenure at P&G, he served as Group President – New Business Creation and Innovation from 2012 until 2013; Group President – Special Assignment from January 2012 until March 2012; Group President, Global Fabric Care from 2007 to 2011; President, Global Home Care from 2001 to 2007; and President of Commercial Products and President of P&G Professional from 2006 to 2007.
高管简历
中英对照 |  中文 |  英文- James A. Rechtin
James A. Rechtin, 2011年加入Humana, 2013年担任首席执行官。在过去的十年中,他领导公司从一家健康保险公司转型为今天的更广泛的医疗保健公司,将健康保险与医疗保健服务相结合。Rechtin从Envision Healthcare加入Humana,担任总裁兼首席执行官。他拥有超过22年的医疗保健经验,专注于在各种医疗集团环境中提供基于价值的护理,包括对医疗保险优势的深刻理解。加入Envision之前,Rechtin担任OptumCare (UnitedHealth Group的一部分)的总裁。在加入OptumCare之前,Rechtin于2014年加入DaVita Medical Group,担任战略高级副总裁和DaVita Medical Group加利福尼亚市场总裁。此外,他是Bain & Company的14年资深员工,突出了他在医疗保健合并和整体医疗保健行业的丰富经验。雷克廷是肯塔基人,他的职业生涯始于印第安纳波利斯一家非营利性健康和人类服务诊所的运营,并在刚果的美国和平队服役。他获得了哈佛商学院工商管理硕士学位和德堡大学文学学士学位。他担任DePauw board of Visitors的董事会成员。
James A. Rechtin,joined Humana in January 2024, having served as President and Chief Operating Officer until July 2024. Under his leadership, Humana operates as a leading integrated care delivery model centered on improving health outcomes, driving lower costs, enhancing quality, and providing a simple and personalized member and patient experience.Prior to joining Humana, Mr. Rechtin served as President and CEO at Envision Healthcare. He has more than 22 years of health care experience with a focus on the delivery of value-based care in various medical group settings, including a deep understanding of Medicare Advantage. Prior to joining Envision, Mr. Rechtin served as President of OptumCare, part of UnitedHealth Group. Before that, Mr. Rechtin was with DaVita Medical Group and played the dual roles of Senior Vice President of Corporate Strategy and President of DaVita Medical Group's California market.- James A. Rechtin, 2011年加入Humana, 2013年担任首席执行官。在过去的十年中,他领导公司从一家健康保险公司转型为今天的更广泛的医疗保健公司,将健康保险与医疗保健服务相结合。Rechtin从Envision Healthcare加入Humana,担任总裁兼首席执行官。他拥有超过22年的医疗保健经验,专注于在各种医疗集团环境中提供基于价值的护理,包括对医疗保险优势的深刻理解。加入Envision之前,Rechtin担任OptumCare (UnitedHealth Group的一部分)的总裁。在加入OptumCare之前,Rechtin于2014年加入DaVita Medical Group,担任战略高级副总裁和DaVita Medical Group加利福尼亚市场总裁。此外,他是Bain & Company的14年资深员工,突出了他在医疗保健合并和整体医疗保健行业的丰富经验。雷克廷是肯塔基人,他的职业生涯始于印第安纳波利斯一家非营利性健康和人类服务诊所的运营,并在刚果的美国和平队服役。他获得了哈佛商学院工商管理硕士学位和德堡大学文学学士学位。他担任DePauw board of Visitors的董事会成员。
- James A. Rechtin,joined Humana in January 2024, having served as President and Chief Operating Officer until July 2024. Under his leadership, Humana operates as a leading integrated care delivery model centered on improving health outcomes, driving lower costs, enhancing quality, and providing a simple and personalized member and patient experience.Prior to joining Humana, Mr. Rechtin served as President and CEO at Envision Healthcare. He has more than 22 years of health care experience with a focus on the delivery of value-based care in various medical group settings, including a deep understanding of Medicare Advantage. Prior to joining Envision, Mr. Rechtin served as President of OptumCare, part of UnitedHealth Group. Before that, Mr. Rechtin was with DaVita Medical Group and played the dual roles of Senior Vice President of Corporate Strategy and President of DaVita Medical Group's California market.
- Celeste Mellet
Celeste Mellet,目前担任Global Infrastructure Partners(GIP)的首席财务官,这是一家领先的基础设施基金管理公司,最近被BlackRock收购。在加入GIP之前,她是Evercore的首席财务官、高级董事总经理兼执行副总裁,负责Evercore的财务、战略、税务、信息技术和设施职能。在加入Evercore之前,Mellet是Fannie Mae的执行副总裁兼首席财务官,负责Fannie Mae战略和财务管理职能。在任职Fannie Mae之前,她在Morgan Stanley工作了超过18年,最后担任全球财务主管,此前担任投资者、债权人和交易对手关系主管。Mellet此前也是一名股票研究分析师,覆盖金融、媒体和博彩住宿领域。
Celeste Mellet,currently serves as CFO of Global Infrastructure Partners (GIP), a leading infrastructure fund manager recently acquired by BlackRock. Prior to joining GIP, she was CFO, senior managing director and executive vice president of Evercore, responsible for the firm's financial, strategy, tax, information technology and facilities functions. Before joining Evercore, Mellet was Fannie Mae's executive vice president and CFO responsible for corporate strategy and financial management functions. Before her tenure at Fannie Mae, she spent more than 18 years at Morgan Stanley, last serving as global treasurer and previously head of investor, creditor and counterparty relations. Mellet was also previously an equity research analyst covering financial, media, and gaming and lodging.- Celeste Mellet,目前担任Global Infrastructure Partners(GIP)的首席财务官,这是一家领先的基础设施基金管理公司,最近被BlackRock收购。在加入GIP之前,她是Evercore的首席财务官、高级董事总经理兼执行副总裁,负责Evercore的财务、战略、税务、信息技术和设施职能。在加入Evercore之前,Mellet是Fannie Mae的执行副总裁兼首席财务官,负责Fannie Mae战略和财务管理职能。在任职Fannie Mae之前,她在Morgan Stanley工作了超过18年,最后担任全球财务主管,此前担任投资者、债权人和交易对手关系主管。Mellet此前也是一名股票研究分析师,覆盖金融、媒体和博彩住宿领域。
- Celeste Mellet,currently serves as CFO of Global Infrastructure Partners (GIP), a leading infrastructure fund manager recently acquired by BlackRock. Prior to joining GIP, she was CFO, senior managing director and executive vice president of Evercore, responsible for the firm's financial, strategy, tax, information technology and facilities functions. Before joining Evercore, Mellet was Fannie Mae's executive vice president and CFO responsible for corporate strategy and financial management functions. Before her tenure at Fannie Mae, she spent more than 18 years at Morgan Stanley, last serving as global treasurer and previously head of investor, creditor and counterparty relations. Mellet was also previously an equity research analyst covering financial, media, and gaming and lodging.
- Vishal Agrawal
Vishal Agrawal担任首席战略和企业发展官,于2018年12月加入公司。在加入公司之前,Agrawal博士是Carlyle Group LP的高级顾问,自2017年10月至2018年12月担任该职位。之前, Agrawal博士是Ciox Health的总裁兼首席发展官,Ciox Health是2015年12月至2018年10月在美国最大的健康信息交换和信息服务组织发布。在加入Ciox Health之前,Agrawal博士曾担任Harris Healthcare的总裁 2013年1月至2015年12月的解决方案。
Vishal Agrawal,serves as Chief Strategy and Corporate Development Officer, having joined the Company in December 2018. Prior to joining the Company, Dr. Agrawal was Senior Advisor for The Carlyle Group L.P., having held that position from October 2017 to December 2018. Previously, Dr. Agrawal was President and Chief Growth Officer of Ciox Health, the largest health information exchange and release of information services organization in the U.S. from December of 2015 to October 2018. Prior to joining Ciox Health, Dr. Agrawal served as President of Harris Healthcare Solutions from January 2013 to December 2015.- Vishal Agrawal担任首席战略和企业发展官,于2018年12月加入公司。在加入公司之前,Agrawal博士是Carlyle Group LP的高级顾问,自2017年10月至2018年12月担任该职位。之前, Agrawal博士是Ciox Health的总裁兼首席发展官,Ciox Health是2015年12月至2018年10月在美国最大的健康信息交换和信息服务组织发布。在加入Ciox Health之前,Agrawal博士曾担任Harris Healthcare的总裁 2013年1月至2015年12月的解决方案。
- Vishal Agrawal,serves as Chief Strategy and Corporate Development Officer, having joined the Company in December 2018. Prior to joining the Company, Dr. Agrawal was Senior Advisor for The Carlyle Group L.P., having held that position from October 2017 to December 2018. Previously, Dr. Agrawal was President and Chief Growth Officer of Ciox Health, the largest health information exchange and release of information services organization in the U.S. from December of 2015 to October 2018. Prior to joining Ciox Health, Dr. Agrawal served as President of Harris Healthcare Solutions from January 2013 to December 2015.
- Joseph C. Ventura
Joseph C. Ventura目前担任首席法律官和公司秘书。 彼于二零零九年一月加入本公司,并于二零零九年七月至二零一九年二月期间担任本公司法律部门的多个职位,包括最近担任高级副总裁,副总法律顾问及公司秘书。
Joseph C. Ventura,serves as Chief Legal Officer. He joined the Company in January 2009 and since then has held various positions of increasing responsibility in the Company's Law Department, including most recently, Senior Vice President, Associate General Counsel & Corporate Secretary from July 2017 until February 2019.- Joseph C. Ventura目前担任首席法律官和公司秘书。 彼于二零零九年一月加入本公司,并于二零零九年七月至二零一九年二月期间担任本公司法律部门的多个职位,包括最近担任高级副总裁,副总法律顾问及公司秘书。
- Joseph C. Ventura,serves as Chief Legal Officer. He joined the Company in January 2009 and since then has held various positions of increasing responsibility in the Company's Law Department, including most recently, Senior Vice President, Associate General Counsel & Corporate Secretary from July 2017 until February 2019.
- Michelle A. O'Hara
Michelle A. O'Hara目前担任首席人力资源官,该职位于2025年1月当选。在加入公司之前,O'Hara女士于2019年至2025年在科学应用国际公司(SAIC)担任执行副总裁兼首席人力资源官。在2019年成为首席人力资源官之前,O'Hara女士在上汽集团担任过各种职责不断增加的角色,包括人才获取、综合人才管理、总奖励和人力资源。
Michelle A. O'Hara,currently serves as Chief Human Resources Officer, having been elected to this position in January 2025. Prior to joining the Company, Ms. O'Hara served as Executive Vice President and Chief Human Resources Officer from 2019 to 2025 at Science Applications International Corporation (SAIC). Prior to becoming Chief Human Resources Officer in 2019, Ms. O'Hara held various roles of increasing responsibility at SAIC that included talent acquisition, integrated talent management, total rewards and human resources.- Michelle A. O'Hara目前担任首席人力资源官,该职位于2025年1月当选。在加入公司之前,O'Hara女士于2019年至2025年在科学应用国际公司(SAIC)担任执行副总裁兼首席人力资源官。在2019年成为首席人力资源官之前,O'Hara女士在上汽集团担任过各种职责不断增加的角色,包括人才获取、综合人才管理、总奖励和人力资源。
- Michelle A. O'Hara,currently serves as Chief Human Resources Officer, having been elected to this position in January 2025. Prior to joining the Company, Ms. O'Hara served as Executive Vice President and Chief Human Resources Officer from 2019 to 2025 at Science Applications International Corporation (SAIC). Prior to becoming Chief Human Resources Officer in 2019, Ms. O'Hara held various roles of increasing responsibility at SAIC that included talent acquisition, integrated talent management, total rewards and human resources.
- George Renaudin II
George Renaudin II目前担任医疗保险和医疗补助总裁,于2023年2月当选担任这一职务。他于2004年4月加入公司,此后担任各种领导职务,责任日益增加,最近担任医疗保险总裁。
George Renaudin II,services as President, Medicare & Medicaid, having been elected to this position in February 2023. Mr. Renaudin joined the Company in April 2004 and since then has held various leadership roles of increasing responsibility, most recently holding the position of President, Medicare.- George Renaudin II目前担任医疗保险和医疗补助总裁,于2023年2月当选担任这一职务。他于2004年4月加入公司,此后担任各种领导职务,责任日益增加,最近担任医疗保险总裁。
- George Renaudin II,services as President, Medicare & Medicaid, having been elected to this position in February 2023. Mr. Renaudin joined the Company in April 2004 and since then has held various leadership roles of increasing responsibility, most recently holding the position of President, Medicare.
- John Paul W. Felter
John Paul W. Felter目前担任高级副总裁、首席会计官和财务总监,已于2022年8月当选。加入Humana Inc.公司之前,Felter先生于2022年5月至2022年6月担任OneAmerica Financial Partners,Inc.的投资融资高级总监。在加入OneAmerica之前,Felter先生在安永会计师事务所(Ernst&Young LLP)担任了近11年的高级经理,负责监督公共和私人实体的大型审计业务,专注于医疗保险行业。
John Paul W. Felter,serves as Senior Vice President, Chief Accounting Officer and Controller, having been elected to this position in August 2022. Before joining the Company, Mr. Felter served as Senior Director - Investment Finance for OneAmerica Financial Partners, Inc. in 2022. Prior to OneAmerica, Mr. Felter spent nearly 11 years in multiple roles of increasing responsibility at Ernst & Young LLP where he oversaw large audit engagements for public and private entities with a concentration in the health insurance sector.- John Paul W. Felter目前担任高级副总裁、首席会计官和财务总监,已于2022年8月当选。加入Humana Inc.公司之前,Felter先生于2022年5月至2022年6月担任OneAmerica Financial Partners,Inc.的投资融资高级总监。在加入OneAmerica之前,Felter先生在安永会计师事务所(Ernst&Young LLP)担任了近11年的高级经理,负责监督公共和私人实体的大型审计业务,专注于医疗保险行业。
- John Paul W. Felter,serves as Senior Vice President, Chief Accounting Officer and Controller, having been elected to this position in August 2022. Before joining the Company, Mr. Felter served as Senior Director - Investment Finance for OneAmerica Financial Partners, Inc. in 2022. Prior to OneAmerica, Mr. Felter spent nearly 11 years in multiple roles of increasing responsibility at Ernst & Young LLP where he oversaw large audit engagements for public and private entities with a concentration in the health insurance sector.
- Sanjay K. Shetty
Sanjay K. Shetty,目前担任CenterWell总裁,已于2023年4月当选这一职位。在加入公司之前,Shetty博士在Steward Health Care System工作了近13年,担任过多个高级职务,包括Steward North America总裁、Steward South Region总裁和执行副总裁、Steward Medical Group总裁和Steward Health Care System执行副总裁、企业和业务发展执行副总裁以及Steward Health Care Network总裁。
Sanjay K. Shetty,serves as President, CenterWell, having been elected to this position in April 2023. Prior to joining the Company, Dr. Shetty spent nearly 13 years at Steward Health Care System in multiple senior-level roles, including President of Steward North America, President, Steward South Region and Executive Vice President, President, Steward Medical Group and Executive Vice President, Steward Health Care System, Executive Vice President for Corporate and Business Development, and President, Steward Health Care Network.- Sanjay K. Shetty,目前担任CenterWell总裁,已于2023年4月当选这一职位。在加入公司之前,Shetty博士在Steward Health Care System工作了近13年,担任过多个高级职务,包括Steward North America总裁、Steward South Region总裁和执行副总裁、Steward Medical Group总裁和Steward Health Care System执行副总裁、企业和业务发展执行副总裁以及Steward Health Care Network总裁。
- Sanjay K. Shetty,serves as President, CenterWell, having been elected to this position in April 2023. Prior to joining the Company, Dr. Shetty spent nearly 13 years at Steward Health Care System in multiple senior-level roles, including President of Steward North America, President, Steward South Region and Executive Vice President, President, Steward Medical Group and Executive Vice President, Steward Health Care System, Executive Vice President for Corporate and Business Development, and President, Steward Health Care Network.
- David E. Dintenfass
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Japan A. Mehta
Japan A. Mehta,目前担任首席信息官,已于2025年2月当选该职位。在加入公司之前,Mehta先生于2018年至2025年期间在花旗集团担任了六年的首席数据官。此前,他曾在花旗全球财富的多个客户群中担任首席信息官一职。此外,他还曾担任Global Consumer技术亚太和欧洲的首席信息官。在加入花旗之前,Mehta先生曾在摩根大通、巴克莱银行和威瑞森通信担任技术和数字领导职务。
Japan A. Mehta,currently serves as Chief Information Officer, having been elected to this position in February 2025. Prior to joining the Company, Mr. Mehta served as Chief Data Officer at Citigroup for six years from 2018 to 2025. Previously, he held the role of CIO for Citi Global Wealth across a mix of client segments. Additionally, he served in the CIO role for Global Consumer Technology in Asia Pacific and Europe. Prior to Citi, Mr. Mehta held technology and digital leadership roles at JPMorgan, Barclays and Verizon.- Japan A. Mehta,目前担任首席信息官,已于2025年2月当选该职位。在加入公司之前,Mehta先生于2018年至2025年期间在花旗集团担任了六年的首席数据官。此前,他曾在花旗全球财富的多个客户群中担任首席信息官一职。此外,他还曾担任Global Consumer技术亚太和欧洲的首席信息官。在加入花旗之前,Mehta先生曾在摩根大通、巴克莱银行和威瑞森通信担任技术和数字领导职务。
- Japan A. Mehta,currently serves as Chief Information Officer, having been elected to this position in February 2025. Prior to joining the Company, Mr. Mehta served as Chief Data Officer at Citigroup for six years from 2018 to 2025. Previously, he held the role of CIO for Citi Global Wealth across a mix of client segments. Additionally, he served in the CIO role for Global Consumer Technology in Asia Pacific and Europe. Prior to Citi, Mr. Mehta held technology and digital leadership roles at JPMorgan, Barclays and Verizon.